Metropolitan Life Insurance Company (MetLife)’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,666
| Closed | -$2.47K | – | 1162 |
|
|
2024
Q1 | $2.47K | Buy |
+1,666
| New | +$2.47K | ﹤0.01% | 2282 |
|
|
2023
Q4 | – | Sell |
-7,125
| Closed | -$8.41K | – | 2370 |
|
|
2023
Q3 | $8.41K | Hold |
7,125
| – | – | ﹤0.01% | 2285 |
|
|
2023
Q2 | $10K | Buy |
+7,125
| New | +$10K | ﹤0.01% | 2297 |
|
|
2022
Q1 | – | Sell |
-17,572
| Closed | -$43.1K | – | 2484 |
|
|
2021
Q4 | $43.1K | Sell |
17,572
-1,506
| -8% | -$3.69K | ﹤0.01% | 2712 |
|
|
2021
Q3 | $48.1K | Sell |
19,078
-19,631
| -51% | -$49.5K | ﹤0.01% | 2766 |
|
|
2021
Q2 | $110K | Buy |
+38,709
| New | +$110K | ﹤0.01% | 2547 |
|
|
2017
Q4 | – | Sell |
-65,827
| Closed | -$164K | – | 2513 |
|
|
2017
Q3 | $164K | Sell |
65,827
-117
| -0.2% | -$291 | ﹤0.01% | 2357 |
|
|
2017
Q2 | $182K | Hold |
65,944
| – | – | ﹤0.01% | 2390 |
|
|
2017
Q1 | $199K | Buy |
65,944
+8,471
| +15% | +$25.6K | ﹤0.01% | 2270 |
|
|
2016
Q4 | $182K | Sell |
57,473
-8,935
| -13% | -$28.3K | ﹤0.01% | 2400 |
|
|
2016
Q3 | $227K | Buy |
+66,408
| New | +$227K | ﹤0.01% | 2254 |
|
|
2016
Q1 | – | Sell |
-56,003
| Closed | -$185K | – | 2519 |
|
|
2015
Q4 | $185K | Buy |
+56,003
| New | +$185K | ﹤0.01% | 2316 |
|
|
2015
Q2 | – | Sell |
-55,715
| Closed | -$223K | – | 2705 |
|
|
2015
Q1 | $223K | Buy |
+55,715
| New | +$223K | ﹤0.01% | 2010 |
|